Post mortem HLA-DR typing of donor corneas using DNA-hybridization technique

Area of Science:

• Ophthalmology
• Immunogenetics
• Transplantation immunology

Background:

• Corneal grafting is a common surgical procedure.
• Human leukocyte antigen (HLA) matching is increasingly recognized to improve clinical outcomes in corneal transplantation.
• Current HLA typing methods often require donor blood samples taken pre-mortem or shortly post-mortem, posing logistical challenges.

Purpose of the Study:

• To evaluate a DNA hybridization technique for human leukocyte antigen-DR (HLA-DR) donor typing.
• To determine the feasibility of obtaining viable DNA from donor eyes for HLA typing more than 24 hours post-mortem.
• To explore the practical implications of this post-mortem ocular DNA typing method for corneal transplantation.

Main Methods:

• DNA was isolated from donor eyes obtained more than 24 hours post-mortem.
• A DNA hybridization technique was employed for human leukocyte antigen-DR (HLA-DR) typing.
• Donor material was maintained under standard banking conditions prior to analysis.

Main Results:

• Successful HLA-DR typing was achieved using DNA extracted from donor eyes.
• The DNA isolation and typing were feasible even when performed more than 24 hours post-mortem.
• This method circumvents the need for pre-mortem or immediate post-mortem blood samples.

Conclusions:

• Post-mortem ocular DNA typing for HLA-DR is a viable alternative to traditional serological methods.
• This technique offers a practical solution for HLA matching in corneal transplantation, especially when timely blood samples are unavailable.
• Implementing this DNA-based approach can potentially enhance the success rates of corneal grafts.